| James Frank Wall, MD | |
|
4301 Nw 63rd St, Ste 205, Oklahoma City, OK 73116-1504 | |
| (405) 917-9094 | |
| (405) 917-9096 |
| Full Name | James Frank Wall |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 4301 Nw 63rd St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043202377 | NPI | - | NPPES |
| 100032000AD | Medicaid | OK | |
| 100032000A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 14803 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Frank Wall, MD 6608 N Western Ave, Ste 473, Oklahoma City, OK 73116-7326 Ph: (405) 917-9094 | James Frank Wall, MD 4301 Nw 63rd St, Ste 205, Oklahoma City, OK 73116-1504 Ph: (405) 917-9094 |
News Archive
A two year study involving over 560 patients with the newly-diagnosed malignant brain tumors shows that patterns of care are varied and there is a need for new, detailed clinical guidelines for management of brain tumors. The study is published in the Feb. 2, 2005 issue of the Journal of the American Medical Association (JAMA).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
Amgen (NASDAQ: AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.
A 15-year research and advocacy effort to make microwave ovens safer has led to a change in national manufacturing standards that will make microwaves more difficult for young children to open, protecting them from the severe microwave-related burns that scar hundreds of kids under 5 years old in the United States each year.
› Verified 6 days ago
Imari Elena Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4140 W Memorial Rd, Suite 215, Oklahoma City, OK 73120 Phone: 405-242-4030 Fax: 405-242-4031 | |
Kristine Marie Thompson, APRN-CNP Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4140 W Memorial Rd Ste 215, Oklahoma City, OK 73120 Phone: 405-242-4030 Fax: 405-242-4031 | |
John Alan Fuller, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5101 W Memorial Rd, Oklahoma City, OK 73142 Phone: 405-752-9600 Fax: 405-752-9605 | |
Ronan Alexander Bakker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4140 W Memorial Rd Ste 321, Oklahoma City, OK 73120 Phone: 405-748-4726 Fax: 405-607-8497 | |
Dr. Jennifer K. Nelson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11200 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-936-1000 Fax: 405-936-1001 | |
Dr. Julie Anne Strebel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4200 W Memorial Rd, Suite 201, Oklahoma City, OK 73120 Phone: 405-749-4200 Fax: 405-749-4218 | |
Bethany Mckenzie Werner, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 800 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-7770 |